Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, Citurgia Biochemicals has informed that it enclosed revised Standalone unaudited Financial Results for the quarter ended on 30th June, 2023. Further, it has informed that in earlier submission dated 21st October, 2023, Limited Review Report issued by the statutory auditor for the quarter ended on 30th June, 2023 could not be submitted. Except above, there is no change in the results submitted to stock exchange dated 21st October, 2023.
The above information is a part of company’s filings submitted to BSE.
